Elan Stock Price, News & Analysis (NYSE:ELN)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

About Elan (NYSE:ELN)

Elan logoElan Corporation Ltd (Elan), formerly Elan Corporation, plc, is a biotechnology company. The Company is focused on discovering and developing advanced therapies in neurodegenerative and autoimmune diseases. On February 6, 2013, the Company announced that it has entered into an asset purchase agreement with Biogen Idec to transfer to Biogen Idec all Tysabri IP and other assets related to Tysabri. As of 31 December 2012, there were approximately 72,700

Receive ELN News and Ratings via Email

Sign-up to receive the latest news and ratings for ELN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A

Elan (NYSE:ELN) Frequently Asked Questions

What is Elan's stock symbol?

Elan trades on the New York Stock Exchange (NYSE) under the ticker symbol "ELN."

Who are some of Elan's key competitors?

How do I buy Elan stock?

Shares of Elan can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Elan?

Elan's mailing address is Treasury Building Grand Canal Street Lower, DUBLIN, 2, Ireland. The biotechnology company can be reached via phone at +353-1-7094000.

MarketBeat Community Rating for Elan (ELN)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  61 (Vote Outperform)
Underperform Votes:  69 (Vote Underperform)
Total Votes:  130
MarketBeat's community ratings are surveys of what our community members think about Elan and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Elan (NYSE:ELN) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


Elan (NYSE:ELN) Earnings History and Estimates Chart

Earnings by Quarter for Elan (NYSE:ELN)

Elan (NYSE ELN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/24/2013Q213$0.02($0.47)$18.35 million$56.30 millionViewN/AView Earnings Details
4/24/2013Q113$0.05$0.11$0.10 million$0.20 millionViewN/AView Earnings Details
2/6/2013Q412$0.04$0.15$315.45 million$271.00 millionViewN/AView Earnings Details
10/24/2012($0.03)($0.02)ViewN/AView Earnings Details
7/25/2012($0.05)ViewN/AView Earnings Details
4/26/2012$0.04($0.05)ViewN/AView Earnings Details
10/27/2011$0.02$1.15ViewN/AView Earnings Details
7/27/2011($0.02)($0.08)ViewN/AView Earnings Details
4/20/2011($0.03)($0.01)ViewN/AView Earnings Details
2/8/2011($0.04)($0.09)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Elan (NYSE:ELN) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com


Dividend History for Elan (NYSE:ELN)

No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Elan (NYSE ELN)

No insider trades for this company have been tracked by MarketBeat.com


Elan (NYSE ELN) News Headlines


SEC Filings

Elan (NYSE:ELN) SEC Filings

DateFilerForm TypeView

Social Media


Elan (NYSE:ELN) Income Statement, Balance Sheet and Cash Flow Statement


Elan (NYSE ELN) Stock Chart for Tuesday, December, 12, 2017

Loading chart…

This page was last updated on 12/12/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.